Maria Rosaria Raspollini retweeted
A novel classification of testicular sex cord‐stromal tumours from the Testicular Sex Cord‐Stromal Tumour (TESST) group: a collaboration of GUPS and ISUP (open access).
@daniel_berney @GU_Path_Society @IntSocUropath
onlinelibrary.wiley.com/doi/…
Snowy and busy weekend in Brussels for ExCo and Counsil Meetings #ESP #pathology #❤️
🤝The busy weekend at ESP HQ concludes with the meeting of the ESP Council!
ℹ️You may browse the members of the ESP Council and its role via our website: esp-pathology.org/council/
#PathTwitter #PathX
Maria Rosaria Raspollini retweeted
🌍🔬 We were honored to welcome participants from more than 20 countries across the globe, reflecting the truly international reach of our society. With sincere gratitude to all who contributed, we look forward to seeing you again next year in Stockholm at the 2026 ECP. #gupath
2025 ISUP Vienna Multidisciplinary Consensus Conference on Evaluation of Treatment Effects in Prostate and Bladder Cancer #ISUPVienna2025 🇦🇹
📅 11 Sept 2025, immediately following @ESP_Pathology #ECPCongress
Register here:
ISUP-VIENNA-2025.eventbrite.…
Maria Rosaria Raspollini retweeted
I usually refrain from sharing personal achievements but this one is too special, being a keynote lecturship named after one of my most iconic mentors Dr. Juan Rosai @ESP_Pathology European Society of Pathology congress 2025
@TheUSCAP @PennPathLabMed @PennMedicine @ASCP_Chicago @ASCO
Maria Rosaria Raspollini retweeted
🎇What a week! What a Congress! What a #pathology Community!🎆
We conclude this year's #ESPCongress with new record numbers!
We are humbled with the engagement of the Community, wish all a safe return, and looking forward to seeing you in 2026 in Stockholm!
#PathTwitter #PathX
Maria Rosaria Raspollini retweeted
The @IntSocUropath #ISUP Multidisciplinary Expert Consultation Conference on Evaluation of Treatment Effects in #Prostate and #Bladder Cancer at the elegant Josephinum Vienna. The meeting was a success with consensus reached in majority of statements. Congratulations all! #GUPath
Maria Rosaria Raspollini retweeted
🏆ESP is proud to join @ESGO_society and @ESTRO_RT in generating the updated guidelines for management of patients with Endometrial Carcinoma!
🧬🔬🔍
🎙️You may read the joined press release here: esp-pathology.org/wp-content…
📰The paper is available here: thelancet.com/journals/lanoc…
Maria Rosaria Raspollini retweeted
Just published in The Lancet! ‼️🗞️ ESGO-ESTRO-ESP Guidelines for the Management of Patients with Endometrial Carcinoma: 2025 Update
These guidelines are an update from the prior guidelines published in 2021 and cover all relevant aspects of diagnosis, management, follow-up & patient education.
They consider the large body of new evidence in this field & incorporate the
2023 FIGO update, which reflects the improved understanding of the complex nature of the different types of endometrial carcinoma & their underlying biological behaviour.
Read the paper 👉 thelancet.com/journals/lanoc…
Read our press release about this important update 👉 esgo.org
Watch our series of webinars about this update 👉 eacademy.esgo.org
#gynonc #oncoalert @estro_rt @esp_pathology
Path to Fight Cancer #FightCancer #Pathology
🏃Path to Fight Cancer - Morning Run!
During #ESPCongress, we are organising a run for #cancer awareness!
This is a motivating and fun event taking place on Monday, 8 September 2025 at 7:00 am in Donaupark, Vienna.
Info is available via this link:espcongress.org/ecp-run/
#pathX
Maria Rosaria Raspollini retweeted
Maria Rosaria Raspollini retweeted
Are you in Boston, MA for #USCAP25?
Then drop by at the ESP booth (No. 1013) to chat with us!
We will be happy to inform about
🔷the benefits of ESP membership
🔷The #ESPCongress in Vienna
🔷our many, onsite and online, educational activities!
🔷our EQA programmes!
#PathTwitter
Expert Consultation Conference on Intraductal Carcinoma of the Prostate #pathologists #prostate #GUPS #ISUP #Boston2025
GUPS and ISUP have jointly organized. An Expert Consultation Conference to address the issue and controversies on IDC-P
Maria Rosaria Raspollini retweeted
🔬 A busy day for #pathologists performing fine-needle aspiration! This thyroid nodule is particularly challenging… and I 💕 challenges!
Catarina Eloy, Pathologist at IPATIMUP, Porto, Portugal, Chair of the Education subcommittee of ESP #EveryDayPathology #PathTwitter
Maria Rosaria Raspollini retweeted
1/ JUST IN: an 8 year #kidneycancer journey now published in @Nature: “A personalized neoantigen vaccine generates anti-tumor immunity in high-risk renal cell carcinoma”. A trial of #RCC vaccine, led together with first author @BraunMDPhD @YaleCancer and #PatrickOtt #DerinKeskin #CatherineWu @DanaFarber
nature.com/articles/s41586-0…
@DanaFarber_GU @OncoAlert @DFCI_NeoVax
Maria Rosaria Raspollini retweeted
🔬 Daily pathology in action! Discussing a challenging gynaecologic tumour case with Dr Gatius, ESP alumni. Integrating morphology & molecular data is key to precision diagnosis.
Dr Xavier Matias-Guiu, President-elect of ESP, Spain.
#EveryDayPathology
#PathTwitter
Maria Rosaria Raspollini retweeted
Great Initiative from the @ESP_Pathology and a great starting post!
🔬What happens after your biopsy?
1️⃣Careful examination: measuring & marking
2️⃣Processing & staining in vivid pinks/purples
3️⃣ Microscopic analysis to reach a diagnosis.
Every detail matters!
Dr Alexandra Vilaia, ESP Education Subcommittee, ESP Alumni member
#EveryDayPathology
Maria Rosaria Raspollini retweeted
ESP would like to wish to all, the very best for the Holiday Season and for the New Year to bring the best to you and your loved ones!
#PathTwitter #PathX
The role of pathologist in the design and conducting of biomarker-driven trials in cancer: position paper of the European Society of Pathology @xmatiasguiu @ESP_Pathology
Maria Rosaria Raspollini retweeted
🎉🪅🥳ESP is celebrating #InternationalPathologyDay!
#pathology is the foundation of modern #Medicine, and #pathologists play a crucial role for diagnosis, screening and management of many diseases!
We are joined in this glorious day by our affiliated national societies!
#PathX







































